Design, Synthesis and in vitro Evaluation of Primaquine and Diaminoquinazoline Hybrid Molecules Against the Malaria Parasite
Chemistry – An Asian Journal · 17.03.2025 · 20 (6)
DOI: 10.1002/asia.202401366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 24.01.2025. Verfasst von Mukul Kore und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, 333031, India. Hauptthemen laut MEDLINE: Antimalarials, Primaquine, Quinazolines, Drug Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Science and Engineering Research Board.
Abstract (Originalsprache)
In this study, we built on the known inhibitory potential of diaminoquinazolines (DAQs) against different stages of Plasmodium development and designed a convenient two‐step synthesis to combine DAQ with primaquine (PQ) pharmacophore. The PQ‐DAQ hybrids displayed potent in vitro activities in the low nanomolar range (IC 50 135.20–398.80 nM) against all intra‐erythrocytic stages of the drug‐sensitive 3D7 strain, with significant potency enhancement compared to PQ alone (IC 50 9370 nM). These hybrids were also potent at killing drug‐resistant strains (Dd2, Dd2 R539T, IPC4912, CamWT C580Y, and 7G8) in the nanomolar range, with 11 f being the most effective compound (IC 50 172.20–396.60 nM). Notably, for the first time, we present evidence that the DAQ‐based compound 8 and its hybrids can inhibit β ‐hematin formation in vitro with potency (IC 50 0.90–27.80 μM), suggesting hemozoin formation to be one of the potential targets of this series. Lastly, two hybrids with potent antiplasmodial activity were also found to be safe up to 10 μM against human HepG2 cells, suggesting the possibility of achieving host vs parasite selectivity with this series.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, 333031, India.
- Institute of Bioinformatics and Applied Biotechnology, Helix Biotech Park, Electronics City Phase I, Bengaluru, Karnataka, 560100, India.
- ICMR-National Institute of Malaria Research, Field Unit, DHS Building, Campal, Panaji, Goa, 403001, India.
ORCID-Profile: Aniruddha Roy, Shruthi S Vembar, Sandeep Sundriyal
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Science and Engineering Research Board
Zitieren
APA
Kore, M., Rao, A. G., Acharya, D., Kirwale, S. S., Bhanot, A., Govekar, A., Mohanty, A. K., Roy, A., Vembar, S. S., & Sundriyal, S. (2025). Design, Synthesis and in vitro Evaluation of Primaquine and Diaminoquinazoline Hybrid Molecules Against the Malaria Parasite. Chemistry – An Asian Journal, 20(6). https://doi.org/10.1002/asia.202401366
Vancouver
Kore M, Rao AG, Acharya D, Kirwale SS, Bhanot A, Govekar A, et al. Design, Synthesis and in vitro Evaluation of Primaquine and Diaminoquinazoline Hybrid Molecules Against the Malaria Parasite. Chemistry – An Asian Journal. 2025;20(6). doi:10.1002/asia.202401366
BibTeX
@article{Kore2025,
author = {Kore, Mukul and Rao, Anjani G and Acharya, Dimple and Kirwale, Shrikant S and Bhanot, Amritansh and Govekar, Abhishek and Mohanty, Ajeet Kumar and Roy, Aniruddha and Vembar, Shruthi S and Sundriyal, Sandeep},
title = {Design, Synthesis and in vitro Evaluation of Primaquine and Diaminoquinazoline Hybrid Molecules Against the Malaria Parasite},
journal = {Chemistry – An Asian Journal},
year = {2025},
volume = {20},
number = {6},
doi = {10.1002/asia.202401366}
}
EUVIMED